| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |